molecular diagnostics

Access Bio is a company dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. Founded in 2002, it has commercialized products to battle malaria and other serious diseases, and is a trusted partner to international public health agencies and organizations.

antigen testingbiosensor productsin vitro diagnostics research and developmentmanufacturing of rapid diagnostic testsPCR testingserology testing

Agendia is a molecular diagnostics company focused solely on breast cancer, offering genomic testing to personalize early-stage breast cancer treatment. Its MammaPrint and BluePrint tests reveal recurrence risk and tumor biology, with results typically provided within 6 business days. Founded in 2003, the company reports 180+ publications and abstracts, 25,000+ patients enrolled in the FLEX Study, and use of its tests in 45+ countries.

AI-driven digital pathologyclinical research and trialsgenomic testing

Akonni Biosystems, based in Frederick, Maryland, is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems. It maintains a state-of-the-art manufacturing facility of nearly 20,000 square feet and offers the patented TruTip in-tip chemistry platform for nucleic acid purification.

automated sample preparationDNA/RNA extractionmanufacturingnucleic acid purification

Aldatu Biosciences is a public benefit corporation and biotechnology company developing molecular diagnostic assays and products based on real-time PCR. Its proprietary PANDAA (Pan Degenerate Amplification and Adaptation) technology enables target detection in highly variable genomic regions, correcting for sequence diversity so assays need not be redesigned for new viral variants. Its pipeline includes tests for SARS-CoV-2, Lassa virus, drug-resistant HIV variants, and Crimean-Congo haemorrhagic fever virus.

adaptive PCRassay developmentgenotypingmultiplexingpre-amplificationreal-time PCR (RT-PCR)

AleloPharma is a genetic diagnostics company whose mission is to push the limits of genetic diagnostics, giving patients and doctors the power to fight disease through high-precision early detection. Its AleloMAX technology uses a proprietary chemistry design for ultra-specificity and ultra-sensitivity in molecular probing, pathogen testing and biomarker sensing.

biomarker sensinggenetic analysispathogen testing

ALPCO (American Laboratory Products Company) is a global developer and provider of molecular and immunodiagnostic products focused on infectious and gastroenterological diseases. Founded in 1991 as an importer and distributor of immunoassay-based products, it is a producer of immunodiagnostic reagents for specialty testing laboratories. In April 2022 it merged with GeneProof, a molecular diagnostics company offering real-time PCR kits and automated instrument platforms.

immunoassayimmunodiagnosticsnucleic acid extractionReal-time PCRsample-to-answer testing

Altratech has developed a novel multi analyte molecular detection platform, a first-of-its-kind multianalyte diagnostic capable of simultaneously detecting and quantifying DNA, RNA, antibodies, and antigens. By combining concurrent serology and nucleic acid detection within a single system, the platform represents an advance in point-of-care molecular diagnostics. The company's digital molecular diagnostic device is being developed as a fully automated, portable, stand-alone instrument for point-of-care and point-of-need applications. Based in Cork, Irel

microfluidicsPNA probe design and synthesissemiconductor chip design

AmeriPath is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers across the U.S. Its team of over 450 board-certified pathologists and Ph.D. level scientists provide medical diagnostic services in outpatient laboratories owned, operated and managed by AmeriPath, as well as hospitals and ambulatory surgical centers. AmeriPath is part of parent company Quest Diagnostics.

anatomic pathologycytogeneticsCytology and Fine Needle Aspirationdermatopathologyflow cytometryhistologyimmunohistochemistry (IHC)molecular testingspecial stainsTissue consultation

GeneSpark Diagnostics develops a portable molecular diagnostic platform using isothermal LAMP nucleic acid amplification technology, which it states is faster than PCR and just as accurate. The company is developing assays including COVID-19, respiratory, bacterial/AMR bloodstream infection, anthrax, and Candida auris panels, targeting point-of-care, emergency/laboratory, veterinary, and environmental applications.

assay developmentisothermal nucleic acid amplification (LAMP)no cold chain supplyno DNA/RNA extraction required

Anvil Diagnostics Inc. is building next-generation molecular diagnostics for invasive infections. Its proprietary SKIP-Seq™ technology, originating from Rice University, delivers the speed of PCR with the breadth of sequencing on standard digital PCR hardware. Its MycoScan™ assay detects microbial cell-free DNA in plasma, targeting a 3-hour pan-fungal liquid biopsy, launched as a research use only (RUO) product.

algorithmic analysisassay developmentcell-free DNA detectioncomputational biologydigital PCR (dPCR)

Applied BioCode Inc. is an in vitro diagnostics (IVD) manufacturer that designs, develops, and commercializes multiplex panel tests for infectious diseases, along with molecular diagnostic instruments and Barcoded Magnetic Bead technology for clinical and research laboratories.

Barcoded Magnetic Bead technologyData Maskinghigh-throughput multiplexingmultiplex PCRsyndromic panel testing

Aptitude Medical Systems is a startup deep-tech healthcare company whose mission is democratizing diagnostics by empowering individuals to access their health and diagnostic information anytime, anywhere. Aptitude created a simple, accurate, and easy-to-use diagnostic platform that fits in the palm of the hand and allows anyone to run a complex lab-quality PCR test in minutes. Its lead product, the Metrix COVID-19 Test, is the first FDA-authorized molecular diagnostic test to work with saliva or swab samples for at-home and over-the-counter use without p

at-home diagnostic testingPCR testing

Arbor Vita Corporation is a biotechnology company in Fremont, California, focused on discovery, development, and commercialization of proteomic-based diagnostics, molecular diagnostics, and therapeutics. Its proprietary PDZ protein technology and monoclonal antibody library support point-of-care tests for infectious diseases and cancer, and it offers clinical testing through its CLIA-certified laboratory, including COVID-19 testing.

CLIA-certified laboratory testinglateral flow immunochromatographic assaysmonoclonal antibody development and manufacturingPDZ protein technologyproteomic diagnostics

Bench in a Box Technologies is developing a transformative diagnostic platform designed to overcome the limitations of PCR/qPCR in field and low-resource environments. Its patent-pending Template-Assisted Refolding Assay (TARA) platform enables highly specific, electricity-free molecular detection at room temperature, delivering results in ≤5 minutes without refrigeration or lab infrastructure. The company is based in Bay City, MI.

diagnostic assay developmentenzyme-free molecular detectionpoint-of-care diagnostics

Biocartis is an innovative molecular diagnostics company committed to revolutionizing molecular testing with its proprietary Idylla platform. It provides next generation diagnostic solutions aimed at improving clinical practice, with a focus on oncology, offering tests supporting lung, skin, thyroid, colorectal, endometrial, blood, brain and breast cancer. Biocartis is a privately held company headquartered in Mechelen, Belgium, and is active in over 95 countries through distribution partners.

fully automated sample-to-result testingreal-time PCR molecular testingresearch assays

BioFire is a molecular diagnostics company with more than 25 years of molecular experience, setting the standard for syndromic infectious disease testing. It is bioMérieux's Global Center of Excellence for Molecular Diagnostics. Its BIOFIRE System delivers accurate results in about one hour, and its FDA-cleared panels test for viruses, bacteria, parasites, yeast, and antimicrobial resistance genes.

LIS connectivitymultiplex PCR testingPOCT connectivitysyndromic infectious disease diagnostics

Bio-Rad is a global leader in developing and manufacturing a wide range of products for the life science research and clinical diagnostic markets. The company provides instruments, reagents, quality control solutions, and data tools for research, manufacturing, testing, and education, spanning applications from PCR and chromatography to clinical diagnostics and food safety testing.

chromatographyDroplet Digital PCRflow cytometryimmunoassaymanufacturingmonoclonal antibody generationPCR

BioTeke USA is an authorized provider of rapid Antigen and Antibody Test Kits intended for use by trained personnel in the healthcare industry, as well as a supplier of test kits and PCR test tools. The company serves hospital representatives, pharmacists, laboratory professionals, government entities, physician practice groups, and university medical systems.

nucleic acid extractionrapid detection

Biovac Nepal Private Limited is a vaccine research, development and manufacturing company based in Nepal. It specializes in field-based disease surveillance, molecular diagnostic and genomics-based disease detection, and vaccine target evaluation, stabilization and manufacturing. It partners with institutions on vaccine research and development, including the University of Queensland. It aims to produce disease-preventing poultry vaccines developed and manufactured in Nepal and to establish a vaccine production laboratory and manufacturing unit in Banepa

field-based disease surveillancegenomics-based disease detectionGIS and disease modelingMobile Application Developmentnext-generation sequencingvaccine manufacturingvaccine research and development

Cepheid is dedicated to bringing the power of molecular diagnostics to meet the challenges of disease and improve health outcomes. For more than 30 years, it has delivered fully automated, reliable PCR testing to institutions of any size, with a comprehensive global test portfolio spanning respiratory, healthcare-associated infections, sexual and women's health, TB, virology and emerging infectious diseases, and oncology and human genetics. Its GeneXpert system uses a self-contained, single-use cartridge integrating sample extraction, PCR amplification,

detectionfully automated testingLIS interfacing (HL7 and ASTM)multiplex testingPCR amplificationPCR testingsample extraction

Cleaved Diagnostics is a molecular diagnostics company focused on engineering novel CRISPR technology to offer rapid, ultra-sensitive diagnostics for fast and reliable results. Its platform is described as cost-effective, highly sensitive, rapid, and adaptable for detecting a wide range of pathogens and genomic targets.

CRISPR technologypathogen detection

The Istituto di Ricerca Genetica e Biomedica (IRGB) is a research institute of the Consiglio Nazionale delle Ricerche (CNR), with main offices in Monserrato (Cagliari) and secondary sites in Lanusei, Milan and Sassari. It conducts basic and translational research in genetics and biomedical genomics, including rare genetic diseases, cardiovascular diseases, regenerative medicine and oncology.

bioinformatics/high-performance computingcell biologycytogeneticsGenomicsgenotypingliquid biopsymolecular biologyNGS sequencingProteomics

Dxome is a CLIA-certified, CAP-accredited clinical laboratory leveraging advanced genomic technologies to deliver actionable genetic insights that empower healthcare providers to personalize treatments and improve patient care. The laboratory combines cutting-edge genomic technologies with rigorous quality control processes to deliver accurate, reliable molecular testing.

Clinical genomicsnext-generation sequencingpharmacogenomicsSpatial multiomics

ElectraDx Molecular provides molecular tools for clinicians, researchers, laboratories, and hospitals. Its product ecosystem includes the Explorer, Frontier, and Discovery Series, offering multiplexed RT-PCR kits, reagents, and kits for research and veterinary testing. The company is led by founder and CEO Jarrod Provins and is based in San Diego, California.

assay developmentmultiplexed RT-PCRveterinary testing